Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/16/1999CA2299678A1 Tgf.beta. rii receptor nucleic sequence, coded peptide, and uses
12/16/1999CA2293694A1 New carboxypeptidase inhibitor
12/15/1999EP0963999A1 E2f activity inhibitory compounds
12/15/1999EP0963441A1 Inactivation of hiv co-receptors as therapy for hiv infection
12/15/1999EP0963440A1 Improved methods for transducing cells
12/15/1999EP0963437A1 The process for the expression and production of the recombinant human beta-cis interferon
12/15/1999EP0963436A1 Nucleic acid encoding congenital heart disease protein and products related thereto
12/15/1999EP0963434A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
12/15/1999EP0963433A1 Transgenic plants expressing geminivirus genes
12/15/1999EP0963431A1 NOVEL FabH
12/15/1999EP0963377A1 Interleukin-19
12/15/1999EP0963208A1 INHIBITION OF Ii SYNTHESIS
12/15/1999EP0963207A1 Il-12 gene therapy of tumors
12/15/1999EP0963205A1 T1 receptor-like ligand ii
12/15/1999EP0963203A2 Mammalian tolloid-like gene and protein
12/15/1999EP0963197A1 Guanylhydrazones useful for treating diseases associated with t cell activation
12/15/1999EP0963196A2 Hyaluronic drug delivery system
12/15/1999EP0695307B1 Modified protein and peptide pharmaceuticals
12/15/1999EP0668912B1 THE St-B17 SEROTONIN RECEPTOR
12/15/1999EP0643585B1 The use of Lipoprotein Associated Coagulation Inhibitor (LACI) for the preparation of a medicament for the treatment of acute or chronic inflammation.
12/15/1999EP0631505B1 Use of a peptide
12/15/1999EP0584283B1 Osteoinductive protein mixtures and purification processes
12/15/1999EP0567567B1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
12/15/1999EP0414730B1 Chemical Compounds and pharmaceutical compositions capable of releasing a drug
12/15/1999CN1238783A Method and novel compounds for use therein
12/15/1999CN1238782A Colostrinin and uses thereof
12/15/1999CN1238781A Heptapeptide oxytocin analofues
12/15/1999CN1238780A Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
12/15/1999CN1238779A Method and compounds for inhibiting 'beta'-amyloid peptide release and/or synthesis
12/15/1999CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype
12/15/1999CN1238693A Pharmaceutical composition comprising compound having anti-Xa activity and platelet aggregation antagonist compound
12/15/1999CN1238217A Medicinal composition of polypeptide for treating radiation damage
12/15/1999CN1238216A Oral immunity enhancing agent
12/15/1999CN1238184A Method for raising pigs and promoting them stronger
12/15/1999CN1047402C Process for producing synthetic gene of encoding polyporus seed storage albumen
12/15/1999CA2274365A1 Compounds and compositions containing them useful for the transfer of active substances into a cell
12/14/1999US6001991 Antisense oligonucleotide modulation of MDR P-glycoprotein gene expression
12/14/1999US6001989 Nucleotide based endonucleases
12/14/1999US6001988 High affinity nucleic acid ligands to lectins
12/14/1999US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999US6001985 Fusion protein delivery systems and uses thereof
12/14/1999US6001977 Antibody produced by immunizing an animal with an immunoreactive polypeptide from the envelope domain of human immunodeficiency virus; for diagnostic immunoassays and neutralizing antibodies
12/14/1999US6001973 Antagonists of interleukin-15
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001971 Human transcription factor
12/14/1999US6001970 Modified human neuropeptide Y1 Receptors
12/14/1999US6001969 Recombinant TGF-β type II receptor polypeptides
12/14/1999US6001968 Mammalian obese polypeptide; for use in genetic therapy; for the treatment of mammals to control body weight and fat content in mammals; for the detection of modulators of weight control
12/14/1999US6001967 Herpes virus proteinase and method of assaying
12/14/1999US6001965 Human pentapeptide used for testing tumor cells capable of metastases; anticarcinogenic agents; antitumor agents; antiproliferative agents
12/14/1999US6001963 Human neuron receptor binding polypeptide which can play a role in treating, preventing, or reducing effects of diseases; for identifying modulators of the activity of the binding polypeptide; anticarcinogenic agents
12/14/1999US6001962 Adjusted polypeptide which binds to cell surface receptor and activates apoptic response; for in vitro and in situ models that screen for modulators of the cell surface receptors; for treatment of autoimmune, liver, and apoptosis defects
12/14/1999US6001961 Cyclic adhesion inhibitors
12/14/1999US6001960 Small cyclic peptides which are more stable than endogenous cyclic peptides in the human body and can be used as affinity ligands for g-protein-linked receptors
12/14/1999US6001884 (substituted phenylene)alkylaminealkyl phenylene compounds of given formula; administering to treat disorders characterized by abnormal calcium homeostasis such as hyperparathyroidism, paget's disease, osteoporosis and hypertension
12/14/1999US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones
12/14/1999US6001816 Gene therapy for leptin deficiency
12/14/1999US6001815 Depsipeptides containing N-substituted glycine residue
12/14/1999US6001814 Serine protease inhibitors
12/14/1999US6001813 Val-pro containing α-keto oxadiazoles as serine protease inhibitors
12/14/1999US6001812 Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
12/14/1999US6001811 Serine protease inhibitors--N-substituted derivatives
12/14/1999US6001810 Methods for treating retroviral infection
12/14/1999US6001809 Peptide having specified amino acid sequence; antiinflammatory agents, in particular for brain disorders
12/14/1999US6001808 Administering effective amount of gramicidin for therapy and prevention
12/14/1999US6001806 Aministering to patients in need of elevated levels of interferon, drugs selected from polypepides of specified amino acid sequences and a carrier
12/14/1999US6001805 Administering composition containing fibroblast andkerotinocyte proliferatingly effective amount of antimicrobially effective ampioathic peptide having specified amino acid sequences
12/14/1999US6001804 Method of blocking human islet cell immunoglobulin andlymphocytes by contacting them with a polypeptide comprisngspecified amino acid sequences
12/14/1999US6001803 Effecive to expand and differentiate progenitor cells into dendriti cells
12/14/1999US6001802 Antiproliferative agents
12/14/1999US6001801 Administering antidiabetic agent cyclic peptide to inhibit insulin release in patient
12/14/1999US6001800 Atomizing into hot air an aqueous solution of recombitant human erythropoietin to evapororate sprayed particles to dryness, separating
12/14/1999US6001799 Method of treating hepatitis C in non-responders to interferon treatment
12/14/1999US6001653 Human type 2 RNase H
12/14/1999US6001652 Antisense modulation of cREL expression
12/14/1999US6001651 Antisense modulation of LFA-3
12/14/1999US6001649 Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production
12/14/1999US6001648 Optimized minizymes and miniribozymes and uses thereof
12/14/1999US6001632 Human protein disulfide isomerase
12/14/1999US6001630 Hydrolase/lyase enzyme isolated from microorganism; for curing intervertebral disc displacement
12/14/1999US6001624 Mitochondrial adenylate kinase
12/14/1999US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999US6001622 Integrin-linked kinase and its use
12/14/1999US6001621 Protein tyrosine kinases
12/14/1999US6001620 Amino acid sequence of enzyme; for diagnosis, prevention and treatment of autoimmune disorders and cancer; anticarcinogenic agents
12/14/1999US6001618 Haloacetoacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme
12/14/1999US6001606 Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
12/14/1999US6001605 Dna sequence coding for two cytokines; diagnosing human colon cancer; for detecting antiinflammatory agents
12/14/1999US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
12/14/1999US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999US6001600 DNA encoding tests polypeptides
12/14/1999US6001598 Two new human DnaJ-like proteins
12/14/1999US6001596 Growth-associated protease inhibitor heavy chain precursor
12/14/1999US6001594 Human testin
12/14/1999US6001593 Polynucleotide sequence coding muscle fiber protein; for detecting a polynucleotide which codes muscle fiber protein in a sample; for treating or preventing immunological, fertility, and cell migration defects; antitumor agents
12/14/1999US6001589 Selecting tumor, cancer, or cultured cells; cloning a portion of a nucleotide sequence which encodes a protein of interest; sequencing the cloned nucleotide sequence and predicting the amino acid sequence; comparing to non-diseased cells
12/14/1999US6001584 Detecting a cell with terminal kinase activity; contacting a cell component associated with terminal kinase with antibody and detecting interaction; antiproliferative agents
12/14/1999US6001575 Nucleic acid sequences coding glutamate receptor interacting protein; for detecting glutamate receptor in tissues and screening receptor modulating drugs; diagnosis and therapy for infertility, nervous system and memory defects